Mr. Jack Doll is a biological engineering graduate from the University of Georgia. He specializes in electron microscopy and genetic engineering with experience examining binding affinities in amyloid proteins, as well as CRISPR mediated edits to environmental toxin immune pathways in Caenorhabditis elegans. Now in his 6th year at OS Therapies, Mr. Doll has experience in planning, implementation, and the regulatory development process for clinical trials, especially in rare pediatric disease; capital raising in both public and private markets, grant writing, and go-public strategy.
